Sort
21,281 grants matching “influenza”
Exercise-induced immunomodulation in the aged: Mechanisms
$481,340Marian L Kohut · Iowa State University · R01 · FY2011 · AI
Innate Immune Properties of Airway Epithelial Antimicrobial Proteins and Peptides
$481,230Paul B McCray · University Of Iowa · P50 · FY2007 · HL
Durable Visible Light-activated Antivral Coatings for Fabrics Used for Personal P
$481,097Josef Stephan Schneider · Laamscience, Inc. · R44 · FY2010 · OH
Technical Development Component
$480,978Bloodcenter Of Wisconsin, Inc. · U19 · FY2004 · AI
Pulmonary Epithelial Dynamics and Innate Host Defense
$480,973Francis X McCormack · University Of Cincinnati · R01 · FY2020 · HL
Pulmonary Epithelial Dynamics and Innate Host Defense
$480,973Francis X McCormack · University Of Cincinnati · R01 · FY2021 · HL
Genomic analysis of the canonical case of virulence evolution: Myxomatosis in Au
$480,956Andrew F. Read · Pennsylvania State University, The · R01 · FY2016 · AI
Project 4: Epigenetic modifiers of regulatory T cell function following viral pneumonia
$480,936Benjamin David Singer · Northwestern University At Chicago · P01 · FY2024 · HL
Pandemic Potential of H5N1 Influenza Viruses
$480,844Yoshihiro Kawaoka · University Of Wisconsin-Madison · R01 · FY2010 · AI
Intervening with Smoking Parents of Inpatients to Reduce Exposure
$480,835Gwendolyn S Kerby · University Of Colorado Denver · R01 · FY2017 · CA
School Located Influenza Vaccinations for Children: Community-Wide Dissemination
$480,824Peter G Szilagyi · University Of Rochester · R18 · FY2013 · HS
HUMAN ANTIBODY REPERTOIRE TO H INFLUENZAE B
$480,730Children'S Hospital &Res Ctr At Oakland · R37 · FY2000 · AI
Methods for Evaluating Vaccine Efficacy
$480,707M Elizabeth Halloran · Fred Hutchinson Cancer Research Center · R37 · FY2013 · AI
Influenza A Virus Infection of Human Nasal Epithelial Cells
$480,699Andrew S. Pekosz · Johns Hopkins University · R01 · FY2013 · AI
Risk of Viral Emergence from Bats
$480,423Peter Daszak · Ecohealth Alliance, Inc. · R01 · FY2010 · AI
Project 5 - Effects of Nursing Home Payment on Patient-Centered Outcomes for Older Adults and People with ADRD
$480,395Adam Jon Sacarny · National Bureau Of Economic Research · P01 · FY2024 · AG
Vaccine Development Of Nontypeable Haemophilus influenzae/Moraxella catarrhalis
$480,341Xin-Xing Xing Gu · National Institute On Deafness And Other Communication Disorders · ZIA · FY2010 · DC
Containing Bioterroist and Emerging Infectious Diseases
$480,226Ira M Longini · Fred Hutchinson Cancer Research Center · U01 · FY2007 · GM
Novel exosomal niches for alveolar stem cell-bassed repair of ARDS
$480,199Hong-Long Ji · Loyola University Chicago · R01 · FY2023 · HL
Alveolar responses to viral lung infection
$480,132Jaime Lynn Hook · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · HL
DNA Vaccine for Induction of Mucosal Immunity
$480,105David B. Weiner · University Of Pennsylvania · P01 · FY2008 · AI
Alterations In Pulmonary Immune Function And Host Resistance In COX Null Mice
$480,074Darryl C Zeldin · National Institute Of Environmental Health Sciences · Z01 · FY2008 · ES
Phosphatidylserine Receptors in Flavivirus Infection
$480,000Hyeryun None Choe · Scripps Florida · R01 · FY2015 · AI
Household Studies of Influenza and Other Respiratory Viruses
$480,000Arnold S Monto · University Of Michigan At Ann Arbor · R01 · FY2012 · AI
Revealing the Biophysics of the Germinal Center Microenvironment
$480,000Robert Koehler Abbott · University Of Texas Med Br Galveston · DP2 · FY2024 · AI